🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:
ВВЕРХ
#EYEG +24% Eyegate Pharmaceuticals Inc - after receiving an approval from the FDA to initiate PE pilot study.
#ADIL +23% Adial Pharmaceuticals, Inc.
#RIOT +17% Riot Blockchain, Inc.
#ADMA +13% ADMA Biologics, Inc.
#NTRA +10% Natera, Inc.
#XBIO +7% Xenetic Biosciences, Inc.
#AGI +6% Alamos Gold Inc.
#WGO +6% Winnebago Industries, Inc.
#EXK +6% Endeavour Silver Corp.
#VLRX +6% Valeritas Holdings, Inc.
#SNDL +5% SUNDIAL GROWERS INC. - after surging 23% on Friday.
#HMY +5% Harmony Gold Mining Company Limited
#AMBD +5% Abiomed, Inc.
#AG +4% First Majestic Silver Corp.
ВНИЗ
#GLYC -52% GlycoMimetics, Inc. - reported top-line results from Pfizer’s Phase 3 clinical trial evaluating rivipansel in sickle cell disease. Piper Jaffray downgraded GlycoMimetics from Overweight to Neutral and lowered the price target from $20 to $6.
#NVTA -10% Invitae Corporation
#PRCP -7% Perceptron, Inc.- after rising 8% on Friday.
#ON -7% ON Semiconductor Corporation - after the company reported Q2 results.
#JCI -6% Johnson Controls International plc
#SE -6% Sea Limited -after rising 6.86% on Friday.
#CNX -5% CNX Resources Corporation
#CCI -5% Crown Castle International Corp. (REIT)
#MT -4% ArcelorMittal - after dropping 4% on Friday.
#KRUS -4% KURA SUSHI USA, INC. - after climbing 24% on Friday.
#ARGX -3% argenx SE
премаркет США - акции - заметные движения:
ВВЕРХ
#EYEG +24% Eyegate Pharmaceuticals Inc - after receiving an approval from the FDA to initiate PE pilot study.
#ADIL +23% Adial Pharmaceuticals, Inc.
#RIOT +17% Riot Blockchain, Inc.
#ADMA +13% ADMA Biologics, Inc.
#NTRA +10% Natera, Inc.
#XBIO +7% Xenetic Biosciences, Inc.
#AGI +6% Alamos Gold Inc.
#WGO +6% Winnebago Industries, Inc.
#EXK +6% Endeavour Silver Corp.
#VLRX +6% Valeritas Holdings, Inc.
#SNDL +5% SUNDIAL GROWERS INC. - after surging 23% on Friday.
#HMY +5% Harmony Gold Mining Company Limited
#AMBD +5% Abiomed, Inc.
#AG +4% First Majestic Silver Corp.
ВНИЗ
#GLYC -52% GlycoMimetics, Inc. - reported top-line results from Pfizer’s Phase 3 clinical trial evaluating rivipansel in sickle cell disease. Piper Jaffray downgraded GlycoMimetics from Overweight to Neutral and lowered the price target from $20 to $6.
#NVTA -10% Invitae Corporation
#PRCP -7% Perceptron, Inc.- after rising 8% on Friday.
#ON -7% ON Semiconductor Corporation - after the company reported Q2 results.
#JCI -6% Johnson Controls International plc
#SE -6% Sea Limited -after rising 6.86% on Friday.
#CNX -5% CNX Resources Corporation
#CCI -5% Crown Castle International Corp. (REIT)
#MT -4% ArcelorMittal - after dropping 4% on Friday.
#KRUS -4% KURA SUSHI USA, INC. - after climbing 24% on Friday.
#ARGX -3% argenx SE
💥🇺🇸#ADIL Adial Pharmaceuticals submitted a formal request to the U.S. FDA to consider its lead drug candidate, AD04, for expedited review program